Amy

Analyst

Jefferies

Equibles does not estimate personal net worth.

About Amy

Amy is recorded as Analyst at Jefferies. Amy has spoken on 3 investor events across 2 companies, most recently for Ironwood Pharmaceuticals Inc on June 4, 2026. Those appearances were for Relay Therapeutics, Inc. (RLAY) and Ironwood Pharmaceuticals Inc (IRWD). The companies whose calls Amy spoke on are classified in the Healthcare sector.

Amy on recent calls

“Thanks so much for joining us for day two of the Jeffries New York Health Care Conference. I hope everyone's still hanging in there. I'm Amy. I'm the biotech analyst at Jeffries.”

Analyst — Jefferies, Jefferies Global Healthcare Conference · June 4, 2026

“Just two from us, how should we think about the dose response between the 300 and the 400 milligram BID dose? Did patients on 400 have more dose interruptions or are there any differences in baseline characteristics?”

Analyst — Jefferies, Relay Therapeutics Conference Call: Initial Clinical Data for Zovegalisib in Vascular Anomalies · May 19, 2026

“So, first of all, would love to get any color on your decision to go into ER-sensitive patients instead of ER-resistant, like some of your peers where the bar on PFS and OS is lower.”

Analyst — Jefferies, Relay Therapeutics Conference Call: Zovegalisib Triplet Data in Breast Cancer · April 27, 2026